Literature DB >> 15138999

Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.

Kanokwan Kittiniyom1, Michelle Mastronardi, Martha Roemer, Wendy A Wells, E Robert Greenberg, Linda Titus-Ernstoff, Irene F Newsham.   

Abstract

DAL-1/4.1B (EPB41L3)is a member of the protein 4.1 superfamily, which encompasses structural proteins that play important roles in membrane processes via interactions with actin, spectrin, and the cytoplasmic domains of integral membrane proteins. DAL-1/4.1B localizes within chromosomal region 18p11.3, which is affected by loss of heterozygosity (LOH) in various adult tumors. Reintroduction of this protein into DAL-1/4.1B-null lung and breast tumor cell lines significantly reduced the number of cells, providing functional evidence that this protein possesses a growth suppressor function not confined to a single cell type. For characterization of the mutational mechanisms responsible for loss of DAL-1/4.1B function in tumors, the exon-intron structure of DAL-1/4.1B was examined for mutations in 15 normal/tumor pairs of non-small cell lung carcinoma by single-strand conformation polymorphism analysis. These studies revealed that small intragenic mutations are uncommon in DAL-1/4.1B. Furthermore, LOH analysis on 129 informative early-stage breast tumors utilizing a new intragenic C/T single-nucleotide polymorphism in exon 14 revealed that LOH resulted in preferential retention of the C-containing allele, suggesting that allele-specific loss is occurring. These studies indicate that mechanisms such as imprinting or monoallelic expression in combination with loss of heterozygosity may be responsible for loss of the DAL-1/4.1B protein in early breast disease. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138999     DOI: 10.1002/gcc.20034

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  11 in total

1.  tSNP-based identification of allelic loss of gene expression in a patient with a balanced chromosomal rearrangement.

Authors:  Gregory F Guzauskas; Kennedy Ukadike; Lynn Rimsky; Anand K Srivastava
Journal:  Genomics       Date:  2007-01-22       Impact factor: 5.736

2.  Cardiac muscle cell cytoskeletal protein 4.1: analysis of transcripts and subcellular location--relevance to membrane integrity, microstructure, and possible role in heart failure.

Authors:  Pamela M Taylor-Harris; Lisa A Keating; Alison M Maggs; Gareth W Phillips; Emma J Birks; Rodney C G Franklin; Magdi H Yacoub; Anthony J Baines; Jennifer C Pinder
Journal:  Mamm Genome       Date:  2005-03       Impact factor: 2.957

Review 3.  Tumor suppressor role of protein 4.1B/DAL-1.

Authors:  Zi Wang; Ji Zhang; Mao Ye; Min Zhu; Bin Zhang; Mridul Roy; Jing Liu; Xiuli An
Journal:  Cell Mol Life Sci       Date:  2014-09-03       Impact factor: 9.261

4.  Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers.

Authors:  Dimitra Dafou; Barbara Grun; John Sinclair; Kate Lawrenson; Elizabeth C Benjamin; Estrid Hogdall; Susanne Kruger-Kjaer; Lise Christensen; Heidi M Sowter; Ahmed Al-Attar; Richard Edmondson; Stephen Darby; Andrew Berchuck; Peter W Laird; C Leigh Pearce; Susan J Ramus; Ian J Jacobs; Simon A Gayther
Journal:  Neoplasia       Date:  2010-07       Impact factor: 5.715

5.  Loss of expression of the differentially expressed in adenocarcinoma of the lung (DAL-1) protein is associated with metastasis of non-small cell lung carcinoma cells.

Authors:  Yajie Zhang; Ruobing Xu; Guiqin Li; Xiaobin Xie; Jie Long; Hongyan Wang
Journal:  Tumour Biol       Date:  2012-07-11

6.  Loss of the putative tumor suppressor band 4.1B/Dal1 gene is dispensable for normal development and does not predispose to cancer.

Authors:  Chunling Yi; Joseph H McCarty; Scott A Troutman; Matthew S Eckman; Roderick T Bronson; Joseph L Kissil
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

7.  Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer.

Authors:  Maria Notaridou; Lydia Quaye; Dimitra Dafou; Chris Jones; Honglin Song; Estrid Høgdall; Susanne K Kjaer; Lise Christensen; Claus Høgdall; Jan Blaakaer; Valerie McGuire; Anna H Wu; David J Van Den Berg; Malcolm C Pike; Aleksandra Gentry-Maharaj; Eva Wozniak; Tanya Sher; Ian J Jacobs; Jonathan Tyrer; Joellen M Schildkraut; Patricia G Moorman; Edwin S Iversen; Anna Jakubowska; Krzysztof Mędrek; Jan Lubiński; Roberta B Ness; Kirsten B Moysich; Galina Lurie; Lynne R Wilkens; Michael E Carney; Shan Wang-Gohrke; Jennifer A Doherty; Mary Anne Rossing; Matthias W Beckmann; Falk C Thiel; Arif B Ekici; Xiaoqing Chen; Jonathan Beesley; Jacek Gronwald; Peter A Fasching; Jenny Chang-Claude; Marc T Goodman; Georgia Chenevix-Trench; Andrew Berchuck; C Leigh Pearce; Alice S Whittemore; Usha Menon; Paul D P Pharoah; Simon A Gayther; Susan J Ramus
Journal:  Int J Cancer       Date:  2011-05-01       Impact factor: 7.396

8.  Band 4.1 proteins regulate integrin-dependent cell spreading.

Authors:  Youngsin Jung; Joseph H McCarty
Journal:  Biochem Biophys Res Commun       Date:  2012-09-06       Impact factor: 3.575

9.  Loss, mutation and deregulation of L3MBTL4 in breast cancers.

Authors:  Lynda Addou-Klouche; José Adélaïde; Pascal Finetti; Nathalie Cervera; Anthony Ferrari; Ismahane Bekhouche; Fabrice Sircoulomb; Christos Sotiriou; Patrice Viens; Soraya Moulessehoul; François Bertucci; Daniel Birnbaum; Max Chaffanet
Journal:  Mol Cancer       Date:  2010-08-10       Impact factor: 27.401

10.  On the statistical assessment of classifiers using DNA microarray data.

Authors:  N Ancona; R Maglietta; A Piepoli; A D'Addabbo; R Cotugno; M Savino; S Liuni; M Carella; G Pesole; F Perri
Journal:  BMC Bioinformatics       Date:  2006-08-19       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.